Harnessing a revolution in targeting chemistry

Centrose is attaching novel sugars and targeting molecules to enhance the pharmaceutical properties of drugs with established therapeutic potential.

Using the power of CarboConnect® and its sophisticated understanding of cell targeting biology, Centrose is growing its drug pipeline. Cells containing specialized sugars behave quite differently than those that do not. The same can be said for drugs. When attached to drugs, certain sugar types substantially change drug function. Centrose is pioneering scientific breakthroughs in the understanding of sugar chemistry and sugar targeting biology in order to rapidly develop a diverse pipeline of proprietary therapeutics.

Our mission at Centrose is to discover new ways to make better drugs.

figure 1a: anticancer